The role of matrix metalloproteinases in atherothrombosis.

Abstract:

:The matrix metalloproteinase (MMP) family of enzymes is involved in arterial wall extracellular matrix degradation and remodeling. The latter activities have been implicated in a number of normal and pathologic processes, such as atherosclerotic lesion formation and progression, plaque destabilization and rupture, but also in plaque stabilization and healing. As a result, the MMPs have been explored as both therapeutic targets and diagnostic tools for the treatment and diagnosis of atherosclerotic cardiovascular diseases. In this review, we summarize experimental findings, genetic associations, and the biomarker potential of MMPs in atherothrombosis. In addition, the regulation and expression of MMPs in atherosclerotic plaques is discussed, with an emphasis on the role of lipid-derived inflammatory mediators as modulators of MMP activity.

journal_name

Curr Atheroscler Rep

authors

Ketelhuth DF,Bäck M

doi

10.1007/s11883-010-0159-7

subject

Has Abstract

pub_date

2011-04-01 00:00:00

pages

162-9

issue

2

eissn

1523-3804

issn

1534-6242

journal_volume

13

pub_type

杂志文章,评审
  • Low-density lipoprotein reduction: is the risk worth the benefit?

    abstract::Outcomes from recent lipid-lowering trials have led to an update of the third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel's guidelines for treatment of hypercholesterolemia in adults. The updated NCEP guidelines now offer an optional goal of low-density lipoprotein (LDL) cholester...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-006-0060-6

    authors: Sabharwal AK,Boord JB

    更新日期:2006-01-01 00:00:00

  • A review of trials evaluating nonstatin lipid-lowering therapies.

    abstract::Recently reported clinical trials raise doubts on the effectiveness of nonstatin lipid-lowering therapies in reducing the residual risk of cardiovascular events after statin monotherapy. Addition of -torcetrapib to statin therapy increased overall mortality in coronary patients despite a marked increase in high-densit...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0010-1

    authors: Ansell BJ

    更新日期:2009-01-01 00:00:00

  • Planning primary prevention of coronary disease.

    abstract::Effective prevention of the current annual $400 billion losses from atherosclerosis and cardiovascular disease (CVD) will require preventing primary causes rather than just decreasing signs and symptoms (risk factors) produced by those causes. All CVD risk factors predict a likelihood of CVD, but not all are causes of...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-009-0042-6

    authors: Lands B

    更新日期:2009-07-01 00:00:00

  • Advances in Coronary No-Reflow Phenomenon-a Contemporary Review.

    abstract:PURPOSE OF REVIEW:Coronary artery no-reflow phenomenon is an incidental outcome of percutaneous coronary intervention in patients presenting with acute myocardial infarction. Despite advances in pharmacologic and non-pharmacologic therapies, coronary no-reflow phenomenon occurs more commonly than desired. It often resu...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章

    doi:10.1007/s11883-018-0747-5

    authors: Karimianpour A,Maran A

    更新日期:2018-07-05 00:00:00

  • The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia.

    abstract:PURPOSE OF REVIEW:We aimed to summarize recent guidelines, position papers, and high-quality clinical research relating the use of nutraceuticals in the management of individuals at high risk of atherosclerotic cardiovascular disease. RECENT FINDINGS:It is essential that individuals at high risk of cardiovascular dise...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00887-z

    authors: Penson PE,Banach M

    更新日期:2020-09-18 00:00:00

  • The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement.

    abstract:PURPOSE OF REVIEW:Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity and overweight. It has a broad spectrum of clinical and histological presentations, such as steatosis, inflammation (known as non-alcoholic steatohepatitis or NASH), fibrosis, and cirrhosis. There is increasing evidence th...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-017-0681-y

    authors: Caravatto PP,Cohen R

    更新日期:2017-10-07 00:00:00

  • The low-density lipoprotein receptor family: genetics, function, and evolution.

    abstract::With ever increasing sophistication in molecular biological approaches, the low-density lipoprotein receptor supergene family continues to grow rapidly. From the well-defined key role of these receptors in lipoprotein metabolism, the new members move the field into many different and diverse physiologic and developmen...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章

    doi:10.1007/s11883-999-0007-9

    authors: Schneider WJ,Nimpf J,Brandes C,Drexler M

    更新日期:1999-09-01 00:00:00

  • Clinical syndromes and management of intracerebral hemorrhage.

    abstract::Spontaneous intracerebral hemorrhage (ICH) is a devastating disease with high morbidity and mortality. Acutely, ICH is associated with a sudden surge in intracranial pressure (ICP), as the volume of hematoma increases the pressure in the closed head, leading to non-specific symptoms of ICP: headache, nausea, vomiting,...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0251-2

    authors: Ko SB,Choi HA,Lee K

    更新日期:2012-08-01 00:00:00

  • Perivascular Adipose Tissue and Coronary Atherosclerosis: from Biology to Imaging Phenotyping.

    abstract:PURPOSE OF REVIEW:Perivascular adipose tissue (PVAT) has a complex, bidirectional relationship with the vascular wall. In disease states, PVAT secretes pro-inflammatory adipocytokines which may contribute to atherosclerosis. Recent evidence demonstrates that pericoronary adipose tissue (PCAT) may also function as a sen...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-019-0817-3

    authors: Lin A,Dey D,Wong DTL,Nerlekar N

    更新日期:2019-11-19 00:00:00

  • Cardiovascular prevention in the cancer survivor.

    abstract::Cancer survivorship should be defined starting not from completion of treatment, but from the time of diagnosis. Assessing and controlling the cancer patient's cardiovascular risk before, during, and after treatment is crucial to improving their overall outcome. There are many cancer therapies, including but not limit...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0484-3

    authors: Chen CL

    更新日期:2015-03-01 00:00:00

  • Pharmacology of antiplatelet agents.

    abstract::Pharmacotherapies with agents that inhibit platelet function have proven to be effective in the treatment of acute coronary syndromes, and in the prevention of complications during and after percutaneous coronary intervention. Because of multiple synergetic pathways of platelet activation and their close interplay wit...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-013-0371-3

    authors: Kalra K,Franzese CJ,Gesheff MG,Lev EI,Pandya S,Bliden KP,Tantry US,Gurbel PA

    更新日期:2013-12-01 00:00:00

  • Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?

    abstract::Numerous retrospective and prospective observational studies support an association between elevated homocysteine and increased risk for myocardial infarction, stroke, and peripheral vascular disease. Although folic acid therapy substantially reduces homocysteine levels, recent large, randomized controlled trials fail...

    journal_title:Current atherosclerosis reports

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s11883-007-0048-x

    authors: Maron BA,Loscalzo J

    更新日期:2007-11-01 00:00:00

  • AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.

    abstract:PURPOSE OF REVIEW:The goal of this manuscript is to summarize the current understanding of the secreted APOA1 binding protein (AIBP), encoded by NAXE, in angiogenesis, hematopoiesis, and inflammation. The studies on AIBP illustrate a critical connection between lipid metabolism and the aforementioned endothelial and im...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-00899-9

    authors: Qiu X,Luo J,Fang L

    更新日期:2020-11-24 00:00:00

  • Lipoprotein apheresis.

    abstract::Lipoprotein apheresis is an extracorporeal therapy whereby apo B-containing lipoproteins (LDL, vLDL, and Lp(a)) are selectively removed from the plasma of a patient. It is a variation of plasma exchange, which non-selectively removes all plasma proteins. Lipoprotein apheresis is most commonly used to treat patients wi...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-015-0516-7

    authors: Bhoj VG,Sachais BS

    更新日期:2015-07-01 00:00:00

  • Modulation of the renin-angiotensin-aldosterone system in heart failure.

    abstract::The renin-angiotensin-aldosterone system (RAAS) is well-established and continues to be pursued as a therapeutic target in the treatment of heart failure, predominantly due to the success of agents that block RAAS in clinical trials of systolic heart failure. The optimal treatment of heart failure patients with preser...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-014-0403-7

    authors: George J,Struthers AD,Lang CC

    更新日期:2014-04-01 00:00:00

  • Microvascular Coronary Dysfunction-an Overview.

    abstract:PURPOSE OF REVIEW:We will review the available data on the epidemiology, pathophysiology, diagnosis, and management of microvascular coronary dysfunction (MCD). RECENT FINDINGS:The study of MCD was pioneered by the Women's Ischemia Syndrome Evaluation (WISE) cohort. New techniques in the diagnosis of this condition, u...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-018-0710-5

    authors: Naderi S

    更新日期:2018-01-30 00:00:00

  • A general assessment of the safety of HMG CoA reductase inhibitors (statins).

    abstract::Few principles in medicine today are as well accepted as the benefits of using statins to reduce cardiovascular risk factors and to prevent cardiovascular disease. The recent withdrawal of a statin (cerivastatin) has lead to a re-examination of all statins, and an attempt to better assess the risk-benefit ratio of thi...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-002-0060-0

    authors: Black DM

    更新日期:2002-01-01 00:00:00

  • Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation.

    abstract::Stroke is the second leading cause of mortality world-wide and is well suited for prevention because it has a high prevalence, high burden of economic cost, well-defined modifiable risk factors, and effective prevention measures. Atherosclerosis is one of the major mechanisms of ischemic stroke, but the apparent diffe...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-006-0012-1

    authors: Bang OY

    更新日期:2006-07-01 00:00:00

  • Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

    abstract::The original version of this article contains errors in Table 3. "At least 1 project/publication in the year" and "> 1 publication per year" have been switched under the titles of "Clinical Track" and "Physician-Scientist track". ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,已发布勘误

    doi:10.1007/s11883-018-0743-9

    authors: Saeed A,Dabhadkar K,Virani SS,Jones PH,Ballantyne CM,Nambi V

    更新日期:2018-06-19 00:00:00

  • Role of cis-Monounsaturated Fatty Acids in the Prevention of Coronary Heart Disease.

    abstract::The effects of cis-monounsaturated fatty acids (cis-MUFAs) on the risk of coronary heart disease (CHD) and on CHD mortality are not clear. Also, dietary recommendations for cis-MUFA as derived by various organizations are not in agreement. Earlier studies have mainly focused on the effects of cis-MUFA on serum lipids ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-016-0597-y

    authors: Joris PJ,Mensink RP

    更新日期:2016-07-01 00:00:00

  • Liver X receptors as therapeutic targets in metabolism and atherosclerosis.

    abstract::The liver X receptors (LXRs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. Since their initial identification more than a decade ago, LXRs have been characterized as key transcriptional regulators of lipid and carbohydrate homeostasis. LXRs are activated by the intra...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-008-0013-3

    authors: Nomiyama T,Bruemmer D

    更新日期:2008-02-01 00:00:00

  • Vitamin D, Calcium, and Cardiovascular Disease: A"D"vantageous or "D"etrimental? An Era of Uncertainty.

    abstract::While the function of vitamin D in regulating calcium homeostasis is well established, there has been growing interest in its role in the prevention of numerous chronic diseases, including cardiovascular disease (CVD). There is mounting epidemiological evidence suggesting that vitamin D deficiency is linked to increas...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-017-0637-2

    authors: Chin K,Appel LJ,Michos ED

    更新日期:2017-01-01 00:00:00

  • Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress.

    abstract::Various lifestyle factors have been associated with increasing the risk of stroke. These include lack of exercise, alcohol, diet, obesity, smoking, drug use, and stress. Guidelines endorsed by the Centers for Disease Control and Prevention and the National Institutes of Health recommend that Americans should exercise ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-000-0111-3

    authors: Boden-Albala B,Sacco RL

    更新日期:2000-03-01 00:00:00

  • Statins and diabetes: the good, the bad, and the unknown.

    abstract::The ability for statins to reduce major cardiovascular events and mortality has lead to this drug class being the most commonly prescribed in the world. In particular, the benefit of these drugs in type 2 diabetes (T2D) is well established. In February 2012, the Food and Drug Administration released changes to statin ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-012-0299-z

    authors: Axsom K,Berger JS,Schwartzbard AZ

    更新日期:2013-02-01 00:00:00

  • Calcific Aortic Valve Stenosis and Atherosclerotic Calcification.

    abstract:PURPOSE OF REVIEW:This review summarizes the pathophysiology of calcific aortic valve stenosis (CAVS) and surveys relevant clinical data and basic research that explain how CAVS arises. RECENT FINDINGS:Lipoprotein(a) [Lp(a)], lipoprotein-associated phospholipase A2 (Lp-PLA2), oxidized phospholipids (OxPL), autotaxin, ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-020-0821-7

    authors: de Oliveira Sá MPB,Cavalcanti LRP,Perazzo ÁM,Gomes RAF,Clavel MA,Pibarot P,Biondi-Zoccai G,Zhigalov K,Weymann A,Ruhparwar A,Lima RC

    更新日期:2020-01-07 00:00:00

  • The role of lipoprotein[a] in atherosclerosis.

    abstract::Recent studies confirm and extend previous evidence that lipoprotein (Lp) plays a significant role in atherosclerosis and is one of the top five or six risk factors for cardiovascular disease. In Japanese patients, Lp levels and apo phenotypes are significant predictors for myocardial infarction. Lp levels are signifi...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-000-0026-z

    authors: Morrisett JD

    更新日期:2000-05-01 00:00:00

  • Applied gene therapy in preclinical models of vascular injury.

    abstract::Atherosclerosis remains the major cause of morbidity and mortality in Western countries. Atherothrombotic complications, including vascular occlusions and severe narrowing of nutrient blood vessels in the cerebral, coronary, or peripheral circulation, usually require invasive revascularization strategies. As molecular...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-003-0022-1

    authors: Janssens SP

    更新日期:2003-05-01 00:00:00

  • ICD and CRT use in ischemic heart disease in women.

    abstract::Although the role of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) in improving outcomes in ischemic cardiomyopathy (ICM) has been described, the data regarding gender-based survival outcomes are limited. There is a higher preponderance of non-ischemic cardiomyopathy (NICM) i...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-015-0512-y

    authors: Mehta NK,Abraham WT,Maytin M

    更新日期:2015-06-01 00:00:00

  • Cryptogenic stroke in patients with patent foramen ovale.

    abstract::Paradoxical embolism through a patent foramen ovale (PFO) is a commonly identified potential mechanism of ischemic stroke, especially in young patients. The recurrent stroke rate among young cryptogenic stroke patients with a PFO is modest, but higher than normal for their age. Co-existing atrial septal aneurysm is a ...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-007-0039-y

    authors: Saver JL

    更新日期:2007-10-01 00:00:00

  • The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy.

    abstract::At a time when the lipid management guidelines give more and more emphasis to the identification and treatment of high-risk patients with the metabolic syndrome and diabetes, there is an obvious need to balance the known effects of low-density lipoprotein (LDL) lowering with the new evidence of clinical efficacy deriv...

    journal_title:Current atherosclerosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11883-004-0104-8

    authors: Fazio S,Linton MF

    更新日期:2004-03-01 00:00:00